United States
Securities and Exchange Commission
Form 12b-25
SEC File No.: 333-128226
CUSIP No.: 45822W100
NOTIFICATION OF LATE FILING
| (Check One): | o Form 10-K and Form 10-KSB; | o Form 20-F; | |
| | o Form 11-K; | x Form 10-Q and Form 10-QSB; | o Form N-SAR |
For Period Ended: September 30, 2007 |
| | |
| o | Transition report on Form 10-K |
| o | Transition Report on Form 20-F |
| o | Transition Report on Form 11-K |
| o | Transition Report on Form 10-Q |
| o | Transition Report on Form N-SAR |
| For the Transition Period Ended: ___________________________ |
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates.
PART I: - REGISTRANT INFORMATION
Intellect Neurosciences, Inc. |
| Full Name of Registrant |
| |
| Former Name if Applicable |
7 West 18th Street New York, NY 10011 |
Address of Principal Executive Office (Street and Number) City, State and Zip Code |
PART II - RULES 12B-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)
| | (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| | |
| x | (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the 5th calendar day after the prescribed due date; and |
| | |
| | (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
State below in reasonable detail the reasons why Forms 10-K, 20-F, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.
Intellect Neurosciences, Inc. (the “Company”) is currently obtaining additional information to accurately complete its financial statements for the period ended September 30, 2007. As a result, the Company requires additional time to complete the Form 10-KSB regarding the period ended September 30, 2007 and cannot timely file that form without unreasonable effort or expense.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification.
| Elliot Maza | 212-448-9300 |
| (Name) | (Area Code) (Telephone Number) |
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such reports(s) been filed? If answer is no, identity report(s).
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
x Yes No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
The Company has ceased operations as a shell company since the corresponding period for the last fiscal year. This change occurred during the year ended June 30, 2007. The Company’s Report on Form 10-QSB for the quarter ended September 30, 2007 will reflect results of operations of the Company’s operating company subsidiary, Intellect USA, Inc.
INTELLECT NEUROSCIENCES, INC.
Name of Registrant as Specified in Charter
The registrant has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
| | | |
| | INTELLECT NEUROSCIENCES, INC. |
| | |
| Date: November 15, 2007 | By: | /s/ Elliot Maza | |
| | Elliot Maza |
| | President and Chief Financial Officer |
